Daniela D Weber
Overview
Explore the profile of Daniela D Weber including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
13
Citations
318
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Stefan V, Weber D, Lang R, Kofler B
Cancer Immunol Immunother
. 2024 Nov;
74(1):23.
PMID: 39537934
Immune checkpoint blockade (ICB) is now part of the standard of care in the treatment of many forms of cancer, yet it lacks efficacy in some patients, necessitating adjunct therapies...
2.
Tevini J, Aminzadeh-Gohari S, Weber D, Catalano L, Stefan V, Redl E, et al.
Anal Methods
. 2024 Jul;
16(31):5459-5466.
PMID: 39045617
Mifepristone (RU486, MIF) is a synthetic steroidal hormone with progesterone and glucocorticoid receptor antagonistic characteristics. MIF is commonly used for pharmalogical abortions, but also for the treatment of endometrial and...
3.
Pereira-Vieira J, Weber D, Silva S, Barbosa-Matos C, Granja S, Reis R, et al.
Pharmaceutics
. 2024 Apr;
16(4).
PMID: 38675105
Altered glycolytic metabolism has been associated with chemoresistance in acute myeloid leukemia (AML). However, there are still aspects that need clarification, as well as how to explore these metabolic alterations...
4.
Gregor A, Panteva V, Bruckberger S, Aunon-Lopez A, Blahova S, Blahova V, et al.
J Nutr Biochem
. 2023 Nov;
124:109517.
PMID: 37925090
As we reported previously, caloric restriction (CR) results in an increased concentration of bile acids (BA) in the intestinal mucosa. We now investigated the background of this phenotype, trying to...
5.
Catalano L, Aminzadeh-Gohari S, Weber D, Poupardin R, Stefan V, Smiles W, et al.
Metabolites
. 2023 Aug;
13(8).
PMID: 37623854
Neuroblastoma (NB) is a childhood cancer in which amplification of the MYCN gene is the most acknowledged marker of poor prognosis. MYCN-amplified NB cells rely on both glycolysis and mitochondrial...
6.
Smiles W, Catalano L, Stefan V, Weber D, Kofler B
Mol Metab
. 2023 Jul;
75:101771.
PMID: 37414143
Background: Neuroblastoma is a paediatric malignancy of incredibly complex aetiology. Oncogenic protein kinase signalling in neuroblastoma has conventionally focussed on transduction through the well-characterised PI3K/Akt and MAPK pathways, in which...
7.
Weber D, Aminzadeh-Gohari S, Thapa M, Redtenbacher A, Catalano L, Capeloa T, et al.
Cancer Metab
. 2022 Jul;
10(1):12.
PMID: 35851093
Background: Growing evidence supports the use of low-carbohydrate/high-fat ketogenic diets as an adjunctive cancer therapy. However, it is unclear which genetic, metabolic, or immunological factors contribute to the beneficial effect...
8.
Weber D, Thapa M, Aminzadeh-Gohari S, Redtenbacher A, Catalano L, Feichtinger R, et al.
Cancers (Basel)
. 2021 Jan;
13(3).
PMID: 33498757
Melanomas are genetically and metabolically heterogeneous, which influences therapeutic efficacy and contributes to the development of treatment resistance in patients with metastatic disease. Metabolite phenotyping helps to better understand complex...
9.
Aminzadeh-Gohari S, Weber D, Catalano L, Feichtinger R, Kofler B, Lang R
Biomolecules
. 2020 Oct;
10(10).
PMID: 33007949
Drastically elevated glycolytic activity is a prominent metabolic feature of cancer cells. Until recently it was thought that tumor cells shift their entire energy production from oxidative phosphorylation (OXPHOS) to...
10.
Sternberg F, Leitner J, Aminzadeh-Gohari S, Weber D, Sanio P, Koller A, et al.
J Invest Dermatol
. 2019 Oct;
140(3):707-710.e7.
PMID: 31630847
No abstract available.